The analysis of the permeability process of calcium antagonists in developing transdermal forms with a cardiovascular effect


	Nifedipine 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylic acid dimethyl ester.

Part of: Shyteyeva T, Gubar S, Smielova N, Bezchasnyuk E, Budanova L (2021) The analysis of the permeability process of calcium antagonists in developing transdermal forms with a cardiovascular effect. Pharmacia 68(1): 189-193. https://doi.org/10.3897/pharmacia.68.e37632